AU9756898A - Human prostaglandin receptors and methods of use thereof - Google Patents

Human prostaglandin receptors and methods of use thereof

Info

Publication number
AU9756898A
AU9756898A AU97568/98A AU9756898A AU9756898A AU 9756898 A AU9756898 A AU 9756898A AU 97568/98 A AU97568/98 A AU 97568/98A AU 9756898 A AU9756898 A AU 9756898A AU 9756898 A AU9756898 A AU 9756898A
Authority
AU
Australia
Prior art keywords
methods
prostaglandin receptors
human prostaglandin
human
receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU97568/98A
Inventor
Lena Jonsson
Harry Rutger Lindstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEMINI GENOMICS AB
Original Assignee
GEMINI GENOMICS AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEMINI GENOMICS AB filed Critical GEMINI GENOMICS AB
Publication of AU9756898A publication Critical patent/AU9756898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
AU97568/98A 1998-11-12 1998-11-12 Human prostaglandin receptors and methods of use thereof Abandoned AU9756898A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1998/001803 WO2000029614A1 (en) 1998-11-12 1998-11-12 Human prostaglandin receptors and methods of use thereof

Publications (1)

Publication Number Publication Date
AU9756898A true AU9756898A (en) 2000-06-05

Family

ID=11004776

Family Applications (1)

Application Number Title Priority Date Filing Date
AU97568/98A Abandoned AU9756898A (en) 1998-11-12 1998-11-12 Human prostaglandin receptors and methods of use thereof

Country Status (2)

Country Link
AU (1) AU9756898A (en)
WO (1) WO2000029614A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020076702A1 (en) * 2000-02-17 2002-06-20 Rakesh Anand Methods
WO2002000933A2 (en) * 2000-06-23 2002-01-03 Interleukin Genetics, Inc. Screening assays for identifying modulators of the inflammatory or immune responses
US20040116669A1 (en) * 2001-03-23 2004-06-17 Hisao Tajima Prostaglandin ep1 receptor
WO2004074843A1 (en) * 2003-02-24 2004-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with g-protein coupled receptor prostaglandin e2 ep1 (prostaglandin e2 ep1)
GB0317500D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Treatment of bph
US7320871B2 (en) * 2003-07-14 2008-01-22 Allergan, Inc. Human prostaglandin FP receptor variants and methods of using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985597A (en) * 1993-05-26 1999-11-16 Merck Frosst Canada, Inc. DNA encoding prostaglandin receptor EP1
US5869281A (en) * 1993-06-25 1999-02-09 Merck Frosst Canada Inc. DNA encoding prostaglandin receptor FP
US5747660A (en) * 1995-11-06 1998-05-05 The University Of Colorado Nucleic acid encoding prostaglandin F2α receptor regulatory protein
GB9608133D0 (en) * 1996-04-19 1996-06-26 Gemini International Holdings Diagnostic method and apparatus
WO1998027976A1 (en) * 1996-12-20 1998-07-02 Pfizer Inc. Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists

Also Published As

Publication number Publication date
WO2000029614A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
AU5036198A (en) Methods and devices for collection of soft tissue
AU4520801A (en) Novel substituted phenanthridinones and methods of use thereof
AU6079598A (en) Additive preparation and method of use thereof
AU7361898A (en) Ophthalmologic insertor apparatus and methods of use
AU6763898A (en) Gel sensors and methods of use thereof
AU9805398A (en) Novel human egf receptors and use thereof
AU2022999A (en) Methods and apparatus for perfusion of isolated tissue structure
AU3068699A (en) Skin equivalent and methods of forming and using same
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU4134101A (en) Hormone receptor functional entities and methods of their use
AU1968400A (en) Human vanilloid receptors and their uses
AU3622600A (en) Metalloproteinases and methods of use therefor
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU3118499A (en) Soft tissue reconstructor and method of use
AU2330599A (en) Fluorinated oxyvinyl compounds and methods of preparing and using same
AU9110098A (en) Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
AU3118297A (en) Sok-1 and methods of use
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU9756898A (en) Human prostaglandin receptors and methods of use thereof
AU9569998A (en) Photo-spectrometers, methods of use and manufacture
AU3501700A (en) Human endokine alpha and methods of use
AU6412599A (en) Oxybutynin formulations and methods of use
AU3964499A (en) Agouti-related protein analogs and methods of use
AU2913395A (en) Compositions and methods of making and using human full length trk-b
AU2237899A (en) Human orthologues of wart

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 14, NO 34, PAGE(S) 6038-6040 UNDER THE HEADING APPLICATIONS LAPSED, REFUSED OR WITHDRAWN PLEASE DELETE ALL REFERENCE TO APPLICATION NO. 97568/98, 63579/99, 11440/00, 11867/00, 12897/00 AND 19758/00

MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase